ZBSO reduced the inflammatory response and oxidative stress induced by LPS by inhibiting the TLR4/MyD88/NF-κB signaling pathway, thereby suppressing COPD. The gene discussed is MYD88; the disease is chronic obstructive pulmonary disease.